Experiment 367011

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationFAREED,G: SCOLARO,M: JORDAN,W: SANDERS,N: CHESSON,C: SLATTERY,M: LONG,D: CASTRO,C:. (1997). ALLICIN.. 22(11)
Amount utilized
Compound isolated
DiseaseA STUDY OF TWICE-DAILY ALLICIN TREATMENT (30 MG B.I.D.) IN PATIENTS WITH CRYPTOSPORIDIUJM PARVUM DIARRHEA SHOWED THAT THE DRUG REDUCED THE NUMBER OF BOWEL MOVEMENTS, STABILIZED OR INCREASED BODY WEIGHT AND REDUCED THE PRESENCE OF C.PARVUM IN STOOL SAMPLES. THE FRUG WAS GENERALLY WELL TOLERATED, WITH THE PRIMARY ADVERSE EVENT BEING A STRONG GARLIC ORDOR AND TASTE (1).
Dose amount30.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE